DE3484689D1 - Die verwendung des gal 1 hefe-promotors. - Google Patents

Die verwendung des gal 1 hefe-promotors.

Info

Publication number
DE3484689D1
DE3484689D1 DE8484101937T DE3484689T DE3484689D1 DE 3484689 D1 DE3484689 D1 DE 3484689D1 DE 8484101937 T DE8484101937 T DE 8484101937T DE 3484689 T DE3484689 T DE 3484689T DE 3484689 D1 DE3484689 D1 DE 3484689D1
Authority
DE
Germany
Prior art keywords
gene
gal
segment
promotor
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484101937T
Other languages
English (en)
Inventor
David Botstein
Ronald Wayne Davis
Gerald Ralph Fink
Alison Taunton-Rigby
Robert Gentry Knowlton
Jen-I Mao
Donald Taylor Moir
Christopher Godfrey Goff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oscient Pharmaceuticals Corp
Original Assignee
Collaborative Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23869556&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3484689(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Collaborative Research Inc filed Critical Collaborative Research Inc
Application granted granted Critical
Publication of DE3484689D1 publication Critical patent/DE3484689D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormones [GH] (Somatotropin)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/94—Saccharomyces
    • Y10S435/942—Saccharomyces cerevisiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon
DE8484101937T 1983-02-28 1984-02-23 Die verwendung des gal 1 hefe-promotors. Expired - Lifetime DE3484689D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/470,911 US4661454A (en) 1983-02-28 1983-02-28 GAL1 yeast promoter linked to non galactokinase gene

Publications (1)

Publication Number Publication Date
DE3484689D1 true DE3484689D1 (de) 1991-07-18

Family

ID=23869556

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484101937T Expired - Lifetime DE3484689D1 (de) 1983-02-28 1984-02-23 Die verwendung des gal 1 hefe-promotors.

Country Status (8)

Country Link
US (1) US4661454A (de)
EP (1) EP0123811B1 (de)
JP (1) JPS6058077A (de)
AT (1) ATE64416T1 (de)
CA (1) CA1283373C (de)
DE (1) DE3484689D1 (de)
DK (1) DK97784A (de)
GB (1) GB2137208B (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0128743A3 (de) * 1983-06-07 1985-12-27 Genex Corporation Expression von Fremdgenen in Hefe
EP0132309A3 (de) * 1983-06-27 1985-12-27 The Board Of Trustees Of The Leland Stanford Junior University Regulierbares eukaryotisches Promotorelement
IL71555A (en) * 1984-04-15 1992-06-21 State Of Israel Israel Inst Fo Bovine interferon
US4990446A (en) * 1984-12-06 1991-02-05 Labofina, S.A. Promoters for the expression of foreign genes in yeast, plasmids comprising them, and use thereof for the production of polypeptides
US4861868A (en) * 1985-02-22 1989-08-29 Monsanto Company Production of proteins in procaryotes
US5037806A (en) * 1985-02-22 1991-08-06 Monsanto Company Biologically active method using somatotropins
EP0225887B1 (de) * 1985-04-08 1994-06-08 Amgen Inc. Verfahren und hybridpromotor zur steuerung der exogenen gentranskription
JP2677350B2 (ja) * 1985-08-02 1997-11-17 メルク エンド カムパニ− インコ−ポレ−テツド 発現蛋白の発酵収率増大
JPH0668B2 (ja) * 1985-08-30 1994-01-05 財団法人化学及血清療法研究所 単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド
US5002876A (en) * 1986-09-22 1991-03-26 Phillips Petroleum Company Yeast production of human tumor necrosis factor
US5013652A (en) * 1986-10-14 1991-05-07 Genex Corporation Composite yeast vectors
US5882884A (en) * 1987-06-19 1999-03-16 Lucky Biotech Corporation Expression of proteinaceous sweeteners in yeast
US5487990A (en) * 1988-07-01 1996-01-30 The General Hospital Corporation Glucose-regulated promoter of yeast acetyl-CoA hydrolase
US5057419A (en) * 1988-09-22 1991-10-15 Rutgers University Genetically engineered plasmid and organisms for the production of specialized oils
US5187079A (en) * 1988-12-21 1993-02-16 The Research Foundation Of State University Of New York Glucose-repressible gene for the regulated expression of proteins and expression vector therefor
WO1991014780A1 (en) * 1990-03-21 1991-10-03 Board Of Regents, The University Of Texas System Yeast expression vectors
ATE199391T1 (de) 1990-09-13 2001-03-15 Univ Duke Expression von an g-protein gekoppelten rezeptoren in hefe
JPH04287683A (ja) * 1991-03-14 1992-10-13 Ajinomoto Co Inc 酵母変異株およびそれを利用するペプチドまたは蛋白質　　　　　　　　　　　等の製造方法
GB9226065D0 (en) * 1992-12-14 1993-02-10 Ici Plc Peptides
DE4303744A1 (de) * 1993-02-09 1994-08-11 Univ Autonoma De Nuevo Leon Mo Hundewachstumshormon
DE19534120A1 (de) 1995-09-14 1997-03-20 Hoechst Ag Verwendung von Cytohesin-PH-Peptiden zur Beeinflußung der Adhäsionsfähigkeit von Integrinen
AU1206397A (en) 1995-12-29 1997-07-28 Guilford Pharmaceuticals Inc. Method and kit for detection of multiple protein interactions
US5886151A (en) * 1996-05-03 1999-03-23 Regents Of The University Of Minnesota Candida albicans integrin-like protein
CN1127568C (zh) 1996-10-16 2003-11-12 津莫吉尼蒂克斯公司 成纤维细胞生长因子同系物
US6265186B1 (en) 1997-04-11 2001-07-24 Dsm N.V. Yeast cells comprising at least two copies of a desired gene integrated into the chromosomal genome at more than one non-ribosomal RNA encoding domain, particularly with Kluyveromyces
GB9726897D0 (en) * 1997-12-20 1998-02-18 Zeneca Ltd Process
IL142164A0 (en) 1998-09-23 2002-03-10 Zymogenetics Inc Cytokine receptor zalpha11
DE69939330D1 (de) 1998-12-07 2008-09-25 Zymogenetics Inc Wachstumsfaktor-homologe zvegf-3
TR200101998T2 (tr) 1999-01-07 2002-06-21 Zymogenetics, Inc. Çözünür reseptör BR 43x2 ve kullanım metodları
US7833529B1 (en) 1999-01-07 2010-11-16 Zymogenetics, Inc. Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
EP1881070B1 (de) 1999-03-09 2012-10-03 Zymogenetics, Inc. Menschliche Zytokine als Liganden des Z-Alpha-Rezeptors und Verwendungen davon
IL147336A0 (en) 1999-07-07 2002-08-14 Zymogenetics Inc Human cytokine receptor
EP2194130A1 (de) 1999-12-23 2010-06-09 ZymoGenetics, L.L.C. Zytokin ZCYT018
DE60142511D1 (de) 2000-05-11 2010-08-19 Zymogenetics Inc Zsig33-ähnliche peptide
PT1325115T (pt) 2000-06-26 2016-09-28 Zymogenetics Inc Recetor de citocina zcytor17
EP1939293A3 (de) 2000-06-30 2008-07-09 ZymoGenetics, Inc. Interferonähnliches Protein ZCYTO21
EP1736545A3 (de) 2000-08-08 2007-03-28 ZymoGenetics, Inc. Lösliche Zcyctor 11 Cytokinrezeptoren
WO2002053747A1 (en) 2000-12-28 2002-07-11 Toyota Jidosha Kabushiki Kaisha Process for producing prenyl alcohol
JP2004533997A (ja) 2001-02-20 2004-11-11 ザイモジェネティクス，インコーポレイティド Ｂｃｍａ及びｔａｃｉの両者を結合する抗体
SI1436003T1 (sl) 2001-05-24 2010-02-26 Zymogenetics Inc TACI-imunoglobulinski fuzijski proteini
WO2003040313A2 (en) 2001-11-05 2003-05-15 Zymogenetics, Inc Il-21 antagonists
US7494804B2 (en) 2002-01-18 2009-02-24 Zymogenetics, Inc. Polynucleotide encoding cytokine receptor zcytor17 multimer
ATE401390T1 (de) 2002-01-18 2008-08-15 Zymogenetics Inc Zytokin (zcytor17-ligand)
WO2003089603A2 (en) 2002-04-19 2003-10-30 Zymogenetics, Inc. Cytokine receptor
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
US20080050808A1 (en) * 2002-10-09 2008-02-28 Reed Thomas D DNA modular cloning vector plasmids and methods for their use
US7785871B2 (en) * 2002-10-09 2010-08-31 Intrexon Corporation DNA cloning vector plasmids and methods for their use
ES2303132T3 (es) 2003-08-07 2008-08-01 Zymogenetics, Inc. Preparaciones homogeneas de il-29.
CN1283792C (zh) * 2003-11-14 2006-11-08 余伟明 生物大分子组分相分离法
EP1732946B1 (de) 2004-03-08 2011-07-27 ZymoGenetics, Inc. Dimere fusionsproteine und materialien und verfahren zu deren herstellung
WO2005116231A1 (en) 2004-05-18 2005-12-08 Intrexon Corporation Methods for dynamic vector assembly of dna cloning vector plasmids
WO2006012644A2 (en) 2004-07-29 2006-02-02 Zymogenetics, Inc. Use of il-28 and il-29 to treat cancer
AU2005268917B2 (en) 2004-08-02 2010-05-20 Basf Plant Science Gmbh Method for isolation of transcription termination sequences
CA2596390A1 (en) 2005-02-08 2006-08-17 Zymogenetics, Inc. Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation
WO2006124667A2 (en) 2005-05-12 2006-11-23 Zymogenetics, Inc. Compositions and methods for modulating immune responses
CA2618763A1 (en) 2005-08-09 2007-02-15 Zymogenetics, Inc. Methods for the treatment and prevention of abnormal cell proliferation using taci-fusion molecules
EP1922080A2 (de) * 2005-08-09 2008-05-21 ZymoGenetics, Inc. Verfahren zur behandlung von b-zell-malignomen mittels taci-ig-fusionsmolekül
US8153598B2 (en) * 2005-10-19 2012-04-10 Intrexon Corporation PKD ligands and polynucleotides encoding PKD ligands
CN101489573B (zh) * 2006-05-15 2013-05-22 阿雷斯贸易股份有限公司 用TACI-Ig融合分子治疗自身免疫疾病的方法
EP2164863A4 (de) 2007-06-15 2010-07-28 Univ Arkansas Verfahren zur verabreichung von molekülen an zellen unter verwendung einer rizin-untereinheit und damit in zusammenhang stehende zusammensetzungen
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
EP2193146B1 (de) 2007-09-14 2016-05-25 Adimab, LLC Synthetische antikörperbibliotheken mit rationalem design und ihre verwendung
JP5474809B2 (ja) 2007-11-21 2014-04-16 ロスキレ ユニバーシティ 氷結合活性を備えたポリペプチド
WO2009080054A1 (en) * 2007-12-21 2009-07-02 Ifxa A/S Protease inhibitor
WO2009092806A2 (en) * 2008-01-25 2009-07-30 Aarhus Universitet Selective exosite inhibition of papp-a activity against igfbp-4
DK2274008T3 (da) 2008-03-27 2014-05-12 Zymogenetics Inc Sammensætninger og fremgangsmåder til hæmning af PDGFRBETA og VEGF-A
US8658766B2 (en) 2008-06-27 2014-02-25 Zymogenetics, Inc. Soluble hybrid Fcγ receptors and related methods
EP2580238A1 (de) 2010-06-09 2013-04-17 Zymogenetics, Inc. Dimere vstm3-fusionsproteine sowie zugehörige zusammensetzungen und verfahren
DK2809795T3 (da) 2012-02-01 2019-12-16 Sgi Dna Inc Materialer og fremgangsmåder til syntese af fejlminimerede nukleinsyremolekyler
WO2014202089A2 (en) 2013-06-18 2014-12-24 Roskilde Universitet Variants of anti-freeze polypeptides
CN106318943B (zh) * 2015-06-29 2019-03-05 中国科学院大连化学物理研究所 半乳糖激酶启动子和终止子及其应用
CN106318942B (zh) * 2015-06-29 2018-12-25 中国科学院大连化学物理研究所 一种半乳糖激酶启动子和终止子及其应用
CA2997263C (en) 2015-09-08 2022-10-04 Theripion, Inc. Apoa-1 fusion polypeptides and related compositions and methods
WO2018136163A2 (en) 2016-12-09 2018-07-26 Theripion, Inc. Tandem apoa-1 fusion polypeptides
CN111148763B (zh) 2017-07-20 2023-11-03 Aptevo研究与开发公司 结合于5t4和4-1bb的抗原结合蛋白以及相关组合物和方法
CN111655728B (zh) 2017-12-20 2022-02-22 和铂医药(上海)有限责任公司 结合ctla-4的抗体及其用途
US10150801B1 (en) 2017-12-27 2018-12-11 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
WO2019132765A1 (en) 2017-12-27 2019-07-04 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
WO2021040610A1 (en) 2019-08-26 2021-03-04 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
US10675332B1 (en) 2019-08-26 2020-06-09 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
CN116568317A (zh) 2020-06-22 2023-08-08 免疫实验室私人有限公司 用于癌症治疗的重组多肽和组合
CA3206901A1 (en) 2021-02-19 2022-08-25 Theripion, Inc. Paraoxonase fusion polypeptides and related compositions and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443539A (en) * 1980-02-05 1984-04-17 The Upjohn Company Process for preparing bovine growth hormone
US4666847A (en) * 1981-01-16 1987-05-19 Collaborative Research, Inc. Recombinant DNA means and method
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
EP0128743A3 (de) * 1983-06-07 1985-12-27 Genex Corporation Expression von Fremdgenen in Hefe
EP0132309A3 (de) * 1983-06-27 1985-12-27 The Board Of Trustees Of The Leland Stanford Junior University Regulierbares eukaryotisches Promotorelement

Also Published As

Publication number Publication date
EP0123811A2 (de) 1984-11-07
ATE64416T1 (de) 1991-06-15
JPS6058077A (ja) 1985-04-04
GB2137208A (en) 1984-10-03
CA1283373C (en) 1991-04-23
GB2137208B (en) 1987-05-13
US4661454A (en) 1987-04-28
DK97784D0 (da) 1984-02-24
DK97784A (da) 1984-08-29
GB8405129D0 (en) 1984-04-04
EP0123811B1 (de) 1991-06-12
EP0123811A3 (en) 1986-03-26

Similar Documents

Publication Publication Date Title
DE3484689D1 (de) Die verwendung des gal 1 hefe-promotors.
DK0378382T3 (da) Rekombinant DNA-fremgangsmåde og værtsceller
ATE103333T1 (de) Hohe proteinsyntheserate in hefe.
ES8602138A1 (es) Metodo de controlar la expresion de un gen que codifica una proteinaheterologa deseada.
KR920012442A (ko) 피치아 파스토리스 산성 인산효소 유전자의 dna 단편 및 이를 사용하는 방법
DE3851399T2 (de) Transientes Expressionssystem zur Herstellung von rekombinantem Protein.
ATE169955T1 (de) Verfahren zur herstellug von transgene zea mays- pflanzen, die aus protoplasten oder aus von protopflasten erhaltenen zellen regeneriert wurden
DK101385A (da) Molekylaer kloning og ekspression i industrielle mikroorganismearter
ATE54167T1 (de) Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden.
DE69521752D1 (de) Verfahren für die Herstellung von Proteinen
PT83968A (de) Verfahren zur verbesserung des expression von eukaryontenprotein
DE3485336D1 (de) Verfahren zur expression von alpha-1-antitrypsin in bakterien und dessen verwendung in therapeutischen zusammensetzungen sowie vektoren und bakterien fuer ein solches verfahren und deren herstellung.
DE58909205D1 (de) Expressionsvektor und Verfahren zur regulierbaren Herstellung von Proteinen in Eukaryonten.
ATE107358T1 (de) System der induzierbaren positiven regulation zur verwendung für die herstellung von heterologen proteinen.
DE3688549D1 (de) Verfahren zur expression von genen in hefe, dns-fragmente und plasmide die letztere fragmente enthalten und zur durchfuehrung des verfahrens verwendet werden.
ATE85358T1 (de) Verfahren zur herstellung von plasminogenaktivatoren in prokaryonten.

Legal Events

Date Code Title Description
8363 Opposition against the patent